Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268596 (
EMA
)
2,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The finding of increased levels of immunoglobulin A (IgA) against food antigens in patients with IgA nephropathy prompted the hypothesis of an association between IgA nephropathy and celiac disease (CD). Attention was initially directed to antigliadin antibodies, then to IgA antiendomysial antibodies (IgA-EMA). IgG1-
EMA
have been found in patients with CD with IgA-
EMA
-negative results. The presence of IgA- and IgG1-
EMA
was investigated in 36 patients with IgA nephropathy, 15 patients with other primary
glomerulonephritis
, and 15 patients with lupus nephritis. IgA-
EMA
and IgG1-
EMA
were detected by indirect immunofluorescence analysis. At the time of renal biopsy, the following factors were evaluated: history of macroscopic hematuria, serum creatinine level, urinalysis, 24-hour proteinuria, blood pressure, and histological classification of IgA nephropathy. Sixteen of 36 patients with IgA nephropathy (44.4%) showed
EMA
positivity. Among patients with positive
EMA
, 12 patients (75%) were IgG1-
EMA
positive, 2 patients (12.5%) were IgA-
EMA
positive, and 2 patients (12.5%) were positive for both isotypes. No significant differences were observed between the two groups (
EMA
positive versus
EMA
negative) concerning age, serum creatinine level, macroscopic hematuria, blood pressure, 24-hour proteinuria, or degree of renal histological involvement. IgA- and IgG1-
EMA
were not detected in patients with other primary nephropathies or lupus nephritis. These results, based on the finding of IgG1-
EMA
, suggest a common pathogenetic pathway for CD and IgA nephropathy. On this basis, the presence of IgG1-
EMA
and/or IgA-
EMA
should be investigated in patients with IgA nephropathy. Furthermore, the role of a gluten-free diet in the natural history of IgA nephropathy, at least in
EMA
-positive patients, needs to be ascertained.
...
PMID:Antiendomysial antibodies in Berger's disease. 1204 28